Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2707]

Recent developments in targeted therapies

Dr Stephen Nimer - University of Miami, Miami, USA

Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )

Performance characteristics and stage distribution of invasive epithelial...

Prof Usha Menon - University College London, London, UK

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers ( Prof Usha Menon - University College London, London, UK )

MyPathway guidance of targeted therapy based on molecular profiles

Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA

MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )

Upfront autologous stem cell transplantation for newly diagnosed multiple...

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer?

Prof Charles Ryan and Prof Nick James

ASCO 2016: What is the optimal chemotherapy dosing regimen for prostate cancer? ( Prof Charles Ryan and Prof Nick James )

Advanced RET-rearranged NSCLC

Dr Takashi Seto and Dr Kiyotaka Yoh

Advanced RET-rearranged NSCLC ( Dr Takashi Seto and Dr Kiyotaka Yoh )

Update on olaparib in ovarian cancer

Prof Jonathan Ledermann - University College Hospital Medical School, London, UK

Update on olaparib in ovarian cancer ( Prof Jonathan Ledermann - University College Hospital Medical School, London, UK )

CPX-351 improves outcomes for refractory AML

Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA

$CPX-351 improves outcomes for refractory AML ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )$

ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational...

Prof Nick James and Prof Charles Ryan

ASCO 2016: Accuracy of multi-parametric MRI to predict further investigational biopsy ( Prof Nick James and Prof Charles Ryan )

Radiotherapy modalities for locally advanced non-small cell lung cancer

Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA

Radiotherapy modalities for locally advanced non-small cell lung cancer ( Dr Zhongxing Liao - University of Texas MD Anderson Cancer Center, Houston, USA )

ASCO 2016: Highlights in prostate cancer from days 3 and 4

Dr Eleni Efstathiou, Prof Kurt Miller, Dr Chris Parker and Prof Stephane Oudard

ASCO 2016: Highlights in prostate cancer from days 3 and 4 ( Dr Eleni Efstathiou, Prof Kurt Miller, Dr Chris Parker and Prof Stephane Oudard )

Large disparities found in BCRA testing across ethnicities

Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA

Large disparities found in BCRA testing across ethnicities ( Dr Tuya Pal - Moffitt Cancer Center, Tampa, USA )

More from ecancer